Tansobiosciences' innovation in GPCR functional assay has opened up whole new opportunities in drug discovery.
Reliable and comprehensive GPCR functional assay
making any GPCRs, even orphan receptors, targettable
New! Large-Scale Comprehensive Panels Tanso Biosciences' large-scale comprehensive panels make the most of its innovative functional assay technologies (international patent application filed) and cover industry-leading 297 human GPCRs.
Panel Assay ExampleAntihypertensive agent carvedilol was screened for 200 human non-orphan GPCRs and shown to selectively antagonize α1 and β adrenoceptors.
New!Focused GPCR panel series, FlexPanel48 FlexPanel48 is a cost-effective, flexible panel with 48 human GPCRs powered by our innovative functional assay technologies (international patent application filed).
- Custom Panels
- You can choose any 48 receptors from 200 non-orphan and 94 orphan GPCRs.
- Therapeutic Area Panels
- Thirteen panels focused on as many therapeutic areas. One can start from one of them and customize it as necessary.